Cardiology
Conference Coverage
Will tirzepatide slow kidney function decline in type 2 diabetes?
Compared to insulin glargine, tirzepatide was associated with significantly less new-onset macroalbuminuria in patients with T2D at high...
News
Omega-3 supplement sweet spot found for BP reduction
A meta-analysis of almost 5,000 people found that 2-3 g of omega-3 fatty acids a day is optimal for reducing blood pressure in people with high BP...
News
ADA prioritizes heart failure in patients with diabetes
Patients with diabetes should have annual screening for biomarkers of early-stage heart failure, and treatment should prioritize an SGLT2...
Conference Coverage
The latest on COVID-19 and the heart in children
Cardiac injury caused by acute COVID-19 appears rare, but the risk is clearly associated with male sex and adolescent age.
News
SGLT2 inhibitors as first-line therapy in type 2 diabetes?
Real-world study finds heart failure hospitalization reduction, compared with metformin but not MI, stroke, or overall mortality and with greater...
News
Takotsubo syndrome more deadly in men
Takotsubo syndrome, characterized by acute heart failure and transient ventricular contractile dysfunction, is more common in women but men are...
News
Updated AHA/ASA guideline changes care for spontaneous intracerebral hemorrhage
Several “standard care” therapies for ICH are not as effective as once thought and are no longer recommended in updated guidelines.
News
Mixing BP meds with NSAID may be ‘triple whammy’ for kidneys
In the absence of additional risk factors, there was no indication of an elevated risk for AKI when an ACE inhibitor and NSAID are combined.
News
Myositis guidelines aim to standardize adult and pediatric care
These are the first guidelines on how to manage adult and pediatric patients with idiopathic inflammatory myopathies (IIM).
Article
Substantially enlarged cardiac silhouette
This case highlights an impressive manifestation of a diagnosis that affects many people around the world.